VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

TCT 2021 | Dasatinib prednisone induction prior to transplant for Ph+ ALL

Marc Schwartz, MD, University of Colorado, Aurora, CO, discusses institutional outcomes of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who have been treated with induction dasatinib prednisone prior to transplant. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter